CKD 5
The percentage of patients on the CKD register with hypertension and proteinuria who are treated with an angiotensin coverting enzyme inhibitor (ACE-I) or angiotensin receptor blocker (AEB) (unless a contraindication or side effects are recorded)
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| CKD 5 | 2011 | 670 | 729 | 91.9% | |
| CKD 5 | 2012 | 740 | 820 | 90.2% | |
| CKD 5 | 2013 | 767 | 853 | 89.9% | |
| CKD003 | 2014 | 794 | 857 | 92.7% | |
| CKD003 | 2015 | 783 | 844 | 92.8% | |
| NM84 | 2016 | 584 | 783 | 74.6% | |
| NM84 | 2017 | 512 | 724 | 70.7% | |
| NM84 | 2018 | 626 | 901 | 69.5% | |
| NM84 | 2019 | 467 | 666 | 70.1% | |
| NM84 | 2022 | 520 | 772 | 67.4% |
